NantCapital

They are fast entering a new age. A worldwide shift as significant as any in history. They call it The Cognitive Age. Combining the collective promise of science, technology and communication. And then making it accessible to all people.

Patrick Soon-Shiong

Founder

10 past transactions

NantHealth

Post in 2023
NantHealth is a healthcare company focused on enhancing diagnostics and clinical delivery through the integration of science and technology. It offers an evidence-based platform designed to empower physicians, patients, payers, and researchers by breaking down traditional barriers in the healthcare system. NantHealth develops software and hardware that collect, index, analyze, and interpret a variety of data—including molecular, financial, clinical, and operational information—to improve decision-making in patient care. The company's solutions are particularly aimed at cancer care and aim to provide personalized, genomically-informed approaches to healthcare, ultimately promoting wellness and supporting the development of next-generation healthcare solutions.

Heliogen

Series A in 2020
Heliogen, Inc. is a clean energy technology company based in Pasadena, California, founded in 2013. It specializes in using concentrated solar power to produce renewable fuels such as hydrogen and syngas, aiming to eliminate reliance on fossil fuels in heavy industry. The company has developed innovative systems, including HelioMax, a closed-loop control system for electricity generation and process heat applications, and HelioHeat, which provides carbon-free, ultra-high-temperature heat for sectors like cement, refining, and mining. Heliogen’s AI-enabled modular technology enables the cost-effective delivery of continuous carbon-free energy in the form of heat, power, or green hydrogen, marking a significant advancement in sustainable energy solutions.

Heliogen

Series A in 2018
Heliogen, Inc. is a clean energy technology company based in Pasadena, California, founded in 2013. It specializes in using concentrated solar power to produce renewable fuels such as hydrogen and syngas, aiming to eliminate reliance on fossil fuels in heavy industry. The company has developed innovative systems, including HelioMax, a closed-loop control system for electricity generation and process heat applications, and HelioHeat, which provides carbon-free, ultra-high-temperature heat for sectors like cement, refining, and mining. Heliogen’s AI-enabled modular technology enables the cost-effective delivery of continuous carbon-free energy in the form of heat, power, or green hydrogen, marking a significant advancement in sustainable energy solutions.

PacketFabric

Series B in 2018
PacketFabric, Inc. operates a Network-as-a-Service platform that offers Ethernet-based cloud networking services. Founded in 2015 and headquartered in Culver City, California, the company provides a private layer 2 network designed for secure and scalable connectivity among colocation facilities, major cloud providers, and Internet exchanges. Its platform enables businesses to procure, manage, and control their network connectivity while emphasizing security and cost-effectiveness. By utilizing automated software-defined networking and advanced optical and packet-switching technologies, PacketFabric facilitates dynamic, real-time connectivity services on a terabit scale. All services are accessible through the company's user-friendly portal and API, allowing enterprises to efficiently manage their data transfer needs.

Benitec

Post in 2017
Benitec Biopharma is using patented ‘gene-silencing’ technology to develop drugs for chronic and life-threatening human diseases. Their transformational technology, ddRNAi, targets and ‘turns off’ specific genes related to disease, providing lasting treatment and potentially cure with a single dose. Compared to traditional approaches to RNA intereference, ddRNAi is easier to deliver, safer to us, more targeted and more efficient. Benitec has a pipeline of in-house and partnered drug development programs based on ddRNAI, including Hepatitis C and B, cancer-associated pain and drug-resistant lung cancer. Our Hepatitis C program is nearing clinical trials in 2013. ddRNAi has the potential to silence genes related to thousands of human diseases and is protected by over 40 global patents. The technology is available from Benitec under a variety of licence options.

Veradigm

Post in 2015
Veradigm is a healthcare technology company that focuses on delivering data-driven insights and solutions to enhance healthcare delivery. Operating as a segment of Allscripts Healthcare Solutions, Veradigm integrates various platforms, data, and expertise to provide actionable tools for clinical workflows, research, and analytics. The company offers a range of services, including electronic health records, information connectivity, and population health management. It serves a diverse clientele, including physicians, hospitals, health systems, and life-sciences companies, aiming to improve clinical and financial outcomes through enhanced connectivity and insights. Veradigm's network fosters collaboration among healthcare stakeholders, driving innovation and transforming the healthcare landscape.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.